Friday, 03 April 2020

Japan News

  • Japan pharma to grow at 2% CAGR from 2013-20

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan, claimed a recent report by Research and Markets. The CountryFocus ...Read more

  • APAC healthcare industry becomes cloud friendly

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is embracing the full gamut of cloud provided services from infrastructure...Read more

  • Eisai signs agreement with Epizyme and Roche

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Eisai has signed an agreement with Epizyme and Roche Molecular Systems to collaborate on the development of a companion diagnostic to help Eisai and Epizyme identify patients fo...Read more

  • Takeda, Lundbeck to present depression study data

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    Singapore: Takeda Pharmaceutical and H Lundbeck will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking ...Read more

  • Japan Vaccine begins operation

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2012

    Singapore: Japan Vaccine, a joint venture created by equal investments from Daiichi Sankyo and GlaxoSmithKline, started its operation from July 3, 2012. Japan Vaccine will hold all develop...Read more

  • Japan approves generic drug for osteoporosis

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2012

    Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (generic name) for the treatment of osteoporosis by Ajinomoto Pharmaceutic...Read more

  • Mitsubishi proton system aids cancer therapy in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Mitsubishi Electric to supply its proton beam therapy system for cancer treatment to Tsuyama Chuo Hospital, Japan, led by Mr Yoshinori Ukita, president of Tsuyama Jifu Group, in ...Read more

  • Japan approves reimbursement for Edwards' Sapien XT valve

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Edwards Lifesciences, makers of heart valves and hemodynamic monitoring, has announced that Japan's Central Social Insurance Medical Council (Chuikyo) has approved the recommenda...Read more

  • MTPC completes acquisition of Medicago

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

    Singapore: Japanese drugmaker Mitsubishi Tanabe Pharma Corporation (MTPC) and Canada-based Medicago, a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic pro...Read more

  • Bionest and Scisive merge together

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2012

    Singapore: Bionest Partners and Scisive Consulting have merged to form a global strategy and management consulting firms for the life science industries. The merged companies will operate u...Read more

  • Shionogi launches London headquarter

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be called Shionogi Limited. The new headquarters will form a new era for ...Read more

  • A time to rethink talent management

    Japan |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

            Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It tested their skills to keep pace with the high level of investment and ...Read more

  • Astellas, Merck enter co-promotion deal in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: Astellas Pharma and MSD KK, the Japan unit of US pharma giant Merck, have entered into a co-promotion agreement for ipragliflozin L-proline, a SGLT2 inhibitor, in Japan. Earlier ...Read more

  • Leading CMO to increase customer base in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, and Innomedica, a life sciences busi...Read more

  • Eisai to launch Bi Chocola Collagen and Bi Chocola Collagen Gelée

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Eisai will launch the tablet-type Bi Chocola Collagen and gelée drink-type Bi Chocola Collagen Gelée (both classified by Japan's Ministry of Health, Labour and Welfare as ...Read more

  • Astellas, UCB announce approval of Cimzia in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: Astellas Pharma and UCB announced that UCB Japan has received marketing approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for Cimzia (INN;certolizumab pego...Read more

  • NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, anti-infective products for the treatment and prevention of topical infe...Read more

  • New VP for Government affairs at Astellas

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2014

    Singapore: Mr Marty Golden will be joining Astellas as the new vice president of Government Affairs with effect from July 1, 2014, the company announced. Mr Golden will be leading Federal ...Read more